Terminates AG013 Oral Mucositis Development Program
TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or “the Company”) today provided an update on progress with...
- After Discussions with FDA, NDA Submission Planned for 3Q 2020 under Accelerated Approval Pathway - Reltecimod in conjunction with currently available...
STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's...
INDIANAPOLIS and GALWAY, Ireland, July 10, 2020 /PRNewswire/ -- The Centre for Cell Manufacturing Ireland (CCMI) at the National University of Ireland Galway (NUI Galway)...
BURLINGTON, Mass., July 10, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2020 financial results...
SOUTH SAN FRANCISCO, July 10, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell...
JACKSONVILLE, Fla., July 10, 2020 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) today announced the release of its official scientific statement on...
In the uphill battle to regulate the colossal cannabis market covering the greater Los Angeles, California area, authorities served tax warrants to 12...
Most COVID-19 lesions located in peripheral zone and close to pleura; influenza virus more prone to show mucoid impaction and pleural effusion Leesburg,...
